{
  "report_rows": [
    {
      "kpi": "Revenue",
      "prediction": "BEAT",
      "answer": "pred ~$10.93B vs. cons $10.80B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Diluted EPS",
      "prediction": "BEAT",
      "answer": "pred ~$7.01 vs. cons $6.83",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Free cash flow",
      "prediction": "BEAT",
      "answer": "pred ~($0.30B) vs. cons ~($0.45B)",
      "confidence": "LOW"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY2026 sales guidance",
      "prediction": "UNCHANGED",
      "answer": "guide ~$43.75B vs. cons $43.80B (FY2026)",
      "confidence": "HIGH"
    },
    {
      "kpi": "FY2026 MTM-adjusted EPS guidance",
      "prediction": "UNCHANGED",
      "answer": "guide ~$27.65 vs. cons $27.70 (FY2026)",
      "confidence": "HIGH"
    },
    {
      "kpi": "FY2026 free-cash-flow guidance",
      "prediction": "UNCHANGED",
      "answer": "guide ~$3.30B vs. cons $3.30B (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "B-21 and Space program-charge commentary",
      "prediction": "UNCHANGED",
      "answer": "guide ~$0M incremental EAC charge vs. cons ~$0M (FY2026)",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": 2.1,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 0.8,
  "day5_path": "FADE",
  "day5_rationale": "A modest revenue/EPS beat and clean program execution should produce an initially positive reaction, but unchanged FY2026 sales, EPS, and FCF guideposts imply limited upward out-period estimate revision; the day-1 move should partially fade as investors refocus on B-21 investment, back-end-loaded cash conversion, and unchanged full-year math.",
  "day5_confidence": "MEDIUM"
}